VKTX EPS Estimates
Viking Therapeutics, Inc.
$25.17
-$2.20(-8.04%)
43
Overall
60
Value
40
Tech
31
Quality
Market Cap
$3.16B
Volume
7.58M
52W Range
$24.94 - $43.15
Target Price
$91.28
VKTX EPS estimates: the consensus estimate for Viking Therapeutics, Inc.'s current fiscal year is -$4.46 per share. Quarterly and next-year EPS forecasts, growth estimates and revenue projections follow.
VKTX EPS Estimates
- EPS estimate, current quarter
- $-1.00
- EPS estimate, next quarter
- $-1.02
- EPS estimate, current year
- $-4.46
- EPS estimate, next year
- $-4.08
- EPS growth, 3-year
- -52.47%
| Fiscal year | EPS |
|---|---|
| 2025 | $-3.19 |
| 2024 | $-1.01 |
| 2023 | $-0.91 |
| 2022 | $-0.90 |
| 2021 | $-0.71 |
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | VKTX | $25.17 | -8.0% | 7.58M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Viking Therapeutics, Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW